No results for ‘’
CARE Ratings Ltd
₹1602.70
(0.87%)
Tue, 06 Oct 2026, 02:12 am
Commercial Services
Financial Publishing/Services
24.5KCARE Ratings EV/EBITDA Ratio
| Particulars | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 0 | 0 | 20.13 | 17.25 | 31.37 | 22.81 | 33.05 | 22.19 | 21.18 | 11.79 | 13.56 | 20.23 | 22.82 | 33.18 | 24.09 |
| Price to book ratio | 0 | 0 | 0 | 0 | 0 | 5.39 | 4.63 | 11.93 | 6.71 | 9.39 | 5.98 | 5.29 | 1.82 | 2.06 | 2.34 | 2.84 | 4.65 | 4.09 |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | 11.26 | 9.48 | 16.59 | 9.76 | 16.98 | 10.83 | 9.13 | 3.98 | 4.88 | 6.14 | 6.83 | 10.06 | 8.22 |
| Price to cash flow ratio | 0 | 0 | 0 | 0 | 0 | 25.43 | 15.60 | 28.57 | 23.84 | 32.17 | 26.05 | 26.82 | 0 | 11.79 | 16.32 | 18.88 | 25.49 | 19.32 |
| Enterprise value | 0 | 0 | 0 | 0 | 0 | 2016Cr | 1937Cr | 4160Cr | 2555Cr | 4481Cr | 3314Cr | 2695Cr | 758Cr | 737Cr | 1029Cr | 1381Cr | 2748Cr | 2708Cr |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 0 | 0 | 14.96 | 13.11 | 26.06 | 14.69 | 24.51 | 15.69 | 15.10 | 8.75 | 7.56 | 12.52 | 12.91 | 24.01 | 17.13 |
| Debt to equity ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0.01 | 0.01 | 0.03 | 0.03 | 0.03 |
| Return on equity % | 0 | 48.36 | 49.40 | 34.64 | 34.50 | 28.36 | 28.45 | 32.65 | 31.16 | 31.80 | 29.74 | 23.97 | 15.21 | 15.96 | 12.15 | 12.66 | 14.47 | 18.02 |
CARE Ratings Ltd Enterprise Value to EBITDA Ratio
The CARE Ratings Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate CARE Ratings Ltd's valuation, profitability, and overall financial performance. Tracking the CARE Ratings Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
CARE Ratings Ltd (NSE: CARERATING, BSE: 534804) is currently trading at ₹1602.70, with a market capitalization of ₹4862.77Cr. As a leading company in the Commercial services sector and Financial publishing/Services industry, monitoring the CARE Ratings Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.
CARE Ratings Ltd Enterprise Value to EBITDA Ratio Current Value
The current CARE Ratings Ltd Enterprise Value to EBITDA Ratio stands at 17.13.
The CARE Ratings Ltd Enterprise Value to EBITDA Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
CARE Ratings Ltd Enterprise Value to EBITDA Ratio Historical Trend
The CARE Ratings Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:
- 2024: 17.13
- 2023: 24.01
- 2022: 12.91
- 2021: 12.52
- 2020: 7.56
The decline in CARE Ratings Ltd Enterprise Value to EBITDA Ratio indicates improving financial efficiency or better earnings growth.
What CARE Ratings Ltd Enterprise Value to EBITDA Ratio Indicates for Investors
The CARE Ratings Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of CARE Ratings Ltd.
CARE Ratings Ltd Enterprise Value to EBITDA Ratio Analysis Summary
The CARE Ratings Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking CARE Ratings Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of CARE Ratings Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.